Improved overall survival after contralateral risk‐reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis

B.A.M. Heemskerk-Gerritsen(Erasmus MC), Caroline Seynaeve(Radboud University Nijmegen), C. Marleen Kets, Liesbeth Jansen(Dialyse Centrum Groningen), Thea M. Mooij(The Netherlands Cancer Institute), Margreet G.E.M. Ausems(McGill University Health Centre), Cora M. Aalfs(University of Amsterdam), HEBON(Erasmus MC Cancer Institute), Maartje J. Hooning(Erasmus MC Cancer Institute), Matti A. Rookus(The Netherlands Cancer Institute), Linetta B. Koppert(Erasmus MC Cancer Institute), J.M. Collée, Hanne Meijers-Heijboer(SUNY Upstate Medical University), Hans F. A. Vasen(Leiden University Medical Center), Kristien Keymeulen(Maastricht University), Rob A.�E.�M. Tollenaar(Leiden University Medical Center)
International Journal of Cancer
June 20, 2014
Cited by 215


Related Papers